Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. IDYA
IDYA logo

IDYA News & Events

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

IDYA News

IDEAYA Biosciences Announces Key Clinical Data Presentation

2d agoNewsfilter

IDEAYA Biosciences to Present Key Data at ASCO Meeting

2d agoPRnewswire

U.S. Stocks Close Higher, Led by Tech Sector Gains

Apr 13 2026NASDAQ.COM

Mixed US Stock Performance Amid Soaring Oil Prices

Apr 13 2026NASDAQ.COM

Oil Price Surge Triggers Market Volatility

Apr 13 2026NASDAQ.COM

IDEAYA and Servier Announce Positive Clinical Trial Results

Apr 13 2026NASDAQ.COM

IDEAYA and Servier Announce Positive Results for Darovasertib Clinical Trial

Apr 13 2026PRnewswire

IDEAYA Biosciences Reports Positive Results for Darovasertib in Clinical Trial

Apr 13 2026Newsfilter

IDYA Events

No data

No data

IDYA Monitor News

IDEAYA to Announce Phase 2/3 Trial Results for Darovasertib

Apr 13 2026

IDYA Earnings Analysis

No Data

No Data

People Also Watch